Document is current
Any future updates will be listed below
-
Authors
Bastian, Moritz B. https://orcid.org/0009-0008-2106-9548
Speicher, Tilman
Blickle, Arne
Burgard, Caroline
Bastian, Julius L. D.
Bartholomä, Mark
Schaefer-Schuler, Andrea
Maus, Stephan
Ezziddin, Samer
Rosar, Florian
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04833517 at ClinicalTrials.govDocuments that mention this clinical trial
Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopenia
https://doi.org/10.1186/s13550-025-01280-0
-
Funding
Funding for this research was provided by:
Universität des Saarlandes
- License Information
-
More Information
Article History
Received: 1 May 2025
Accepted: 22 June 2025
First Online: 6 July 2025
Declarations
:
: This study was in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All patients who participated in this study gave their written consent after being informed about risks and potential side effects of this therapy. The study was approved by the local Institutional Review Board (ethics committee permission number 140/17).
: All patients agreed to publication of their data in accordance with the declaration of Helsinki.
: The authors declare that they have no competing interests.
